Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
News on Dr Reddys Laboratories
Dr Reddys launches generic Emend in US market
7.51 am | 12 Sep 2019 | Source: PTI
Fosaprepitant is used with other medications to help prevent nausea and vomiting caused by chemotherapy. The launch follows the approval by the US Foo...
Quick Links for Dr Reddys Laboratories
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.